Planet 13 Holdings (PLNH) Retained Earnings (2021 - 2026)
Planet 13 Holdings (PLNH) reported Retained Earnings of -$328.1 million for Q1 2026, down 27.1% year-over-year from -$450.1 million in Q1 2025, and down 2.53% quarter-over-quarter from -$320.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Retained Earnings (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Retained Earnings data on file, last reported at -$328.1 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$328.1 million, down 27.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$328.1 million (down 27.1% YoY), and the FY2025 annual result was -$320.0 million, down 24.96% from the prior year.
- Retained Earnings eased to -$328.1 million in Q1 2026 per PLNH's latest filing, from -$320.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$74.2 million in Q1 2022 and troughed at -$328.1 million in Q1 2026.
- A 5-year average of -$204.5 million and a median of -$214.2 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings sank 135.19% in 2023, then declined 18.35% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$134.7 million in 2022, then plunged by 54.65% to -$208.3 million in 2023, then fell by 22.94% to -$256.1 million in 2024, then dropped by 24.96% to -$320.0 million in 2025, then retreated by 2.53% to -$328.1 million in 2026.
- Business Quant data shows PLNH's Retained Earnings at -$328.1 million in Q1 2026, -$320.0 million in Q4 2025, and -$315.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | -328.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -328.13 Mn |
| Dec 31, 2025 | -320.03 Mn |
| Sep 30, 2025 | -315.41 Mn |
| Jun 30, 2025 | -271.46 Mn |
| Mar 31, 2025 | -258.15 Mn |
| Dec 31, 2024 | -256.11 Mn |
| Sep 30, 2024 | -229.67 Mn |
| Jun 30, 2024 | -222.26 Mn |
| Mar 31, 2024 | -214.18 Mn |
| Dec 31, 2023 | -208.31 Mn |
| Sep 30, 2023 | -194.05 Mn |
| Jun 30, 2023 | -147.80 Mn |
| Mar 31, 2023 | -143.18 Mn |
| Dec 31, 2022 | -134.70 Mn |
| Sep 30, 2022 | -82.51 Mn |
| Jun 30, 2022 | -76.25 Mn |
| Mar 31, 2022 | -74.22 Mn |
| Dec 31, 2021 | -75.16 Mn |